Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1966 1
1967 1
1969 1
1971 1
1974 1
1979 1
1980 1
1986 1
1988 1
1991 2
1992 4
1993 1
1994 1
1995 1
1996 4
1997 1
1998 2
2000 1
2001 1
2003 1
2005 1
2006 1
2007 3
2009 1
2010 3
2011 5
2012 7
2013 11
2014 7
2015 11
2016 9
2017 6
2018 12
2019 11
2020 3
2021 4
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

112 results
Results by year
Filters applied: . Clear all
Page 1
mTORC1 and mTORC2 in cancer and the tumor microenvironment.
Kim LC, Cook RS, Chen J. Kim LC, et al. Among authors: cook rs. Oncogene. 2017 Apr 20;36(16):2191-2201. doi: 10.1038/onc.2016.363. Epub 2016 Oct 17. Oncogene. 2017. PMID: 27748764 Free PMC article. Review.
Biological Consequences of MHC-II Expression by Tumor Cells in Cancer.
Axelrod ML, Cook RS, Johnson DB, Balko JM. Axelrod ML, et al. Among authors: cook rs. Clin Cancer Res. 2019 Apr 15;25(8):2392-2402. doi: 10.1158/1078-0432.CCR-18-3200. Epub 2018 Nov 21. Clin Cancer Res. 2019. PMID: 30463850 Free PMC article. Review.
RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors.
Loi S, Dushyanthen S, Beavis PA, Salgado R, Denkert C, Savas P, Combs S, Rimm DL, Giltnane JM, Estrada MV, Sánchez V, Sanders ME, Cook RS, Pilkinton MA, Mallal SA, Wang K, Miller VA, Stephens PJ, Yelensky R, Doimi FD, Gómez H, Ryzhov SV, Darcy PK, Arteaga CL, Balko JM. Loi S, et al. Among authors: cook rs. Clin Cancer Res. 2016 Mar 15;22(6):1499-509. doi: 10.1158/1078-0432.CCR-15-1125. Epub 2015 Oct 29. Clin Cancer Res. 2016. PMID: 26515496 Free PMC article.
Efferocytosis in the tumor microenvironment.
Werfel TA, Cook RS. Werfel TA, et al. Among authors: cook rs. Semin Immunopathol. 2018 Nov;40(6):545-554. doi: 10.1007/s00281-018-0698-5. Epub 2018 Sep 5. Semin Immunopathol. 2018. PMID: 30187085 Free PMC article. Review.
Motivation for Launching a Cancer Metastasis Inhibition (CMI) Program.
Pulley JM, Jerome RN, Ogletree ML, Bernard GR, Lavieri RR, Zaleski NM, Hong CC, Shirey-Rice JK, Arteaga CL, Mayer IA, Holroyd KJ, Cook RS. Pulley JM, et al. Among authors: cook rs. Target Oncol. 2018 Feb;13(1):61-68. doi: 10.1007/s11523-017-0542-1. Target Oncol. 2018. PMID: 29218624 Free PMC article. Review.
Clearance of dying cells accelerates malignancy.
Vaught DB, Cook RS. Vaught DB, et al. Among authors: cook rs. Oncotarget. 2015 Sep 22;6(28):24590-1. doi: 10.18632/oncotarget.5670. Oncotarget. 2015. PMID: 26387138 Free PMC article. No abstract available.
112 results